跳至主要内容
临床试验/NCT06007573
NCT06007573已完成不适用

Acupuncture Combined With Nimodipine for Prevention of Post-stroke Dementia:a Randomized Controlled Trial

Yuzhen Pan1 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2021年2月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
40
试验地点
1
主要终点
Response Rate

研究概览

简要总结

To observe the clinical efficacy of TCM acupuncture combined with western medicine nimodipine for prevention of post-stroke dementia by comparing with clinical conventional treatment methods.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
40 Years 至 85 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Definite ischemic stroke or hemorrhagic stroke confirmed by head CT / MRI examination
  • Memory or cognitive and executive dysfunction. Cognitive dysfunction will be determined after the mini mental state evaluation (MMSE) score
  • Age limited to 40-85 years, irrespective of gender
  • Stable condition, clear consciousness, no aphasia, oral medication available
  • No major comorbidity, no major depression
  • Consent and signed patient informed consent

排除标准

  • Had serious medical conditions, such as heart, liver, kidney, or endocrine disease
  • Aphasia or hearing impairment
  • Participants in other clinical trials
  • Patients currently on medication to improve cognitive function

研究组 & 干预措施

treatment group

Experimental

On the basis of the control group treatment, the treatment group also adopted the acupuncture treatment

干预措施: The control group received oral nimodipine tablets (Drug)

control group

Other

The control group received oral nimodipine tablets

干预措施: The control group received oral nimodipine tablets (Drug)

结局指标

主要结局

Response Rate

时间窗: 24 weeks

次要结局

  • Hasegawa Dementia Scale(24 weeks)
  • Montreal Cognitive Assessment(24 weeks)

研究者

发起方
Yuzhen Pan
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Yuzhen Pan

DOCTOR

The Second Affiliated Hospital of Anhui University of Traditional Chinese Medicine

研究点 (1)

Loading locations...

相似试验